Use of extract from Spirulina platensis (Nordst) Getil CNMN-CB-02 cyanobacterium strain biomass for the treatment of patients with sensorineural deafness

摘要

The invention relates to medicine, in particular to otorhinolaryngology and can be used for the treatment of patients with sensorineural deafness.According to the claimed invention, extract from Spirulina platensis (Nordst) Getil CNMN-CB-02 cyanobacterium strain biomass is used for the treatment of patients with sensorineural deafness, 5 mg, 2 times a day, before meals, for 20 days.